A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures. (Q35620650)
Jump to navigation
Jump to search
scientific article published on 4 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures. |
scientific article published on 4 October 2011 |
Statements
A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures (English)
N S Sandanayake
J Sinclair
M H Chapman
A Xue
G J Webster
A Clarkson
A Gill
I D Norton
R C Smith
4 October 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference